1. Home
  2. LOAN vs CNTX Comparison

LOAN vs CNTX Comparison

Compare LOAN & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOAN
  • CNTX
  • Stock Information
  • Founded
  • LOAN 1989
  • CNTX 2015
  • Country
  • LOAN United States
  • CNTX United States
  • Employees
  • LOAN N/A
  • CNTX N/A
  • Industry
  • LOAN Real Estate Investment Trusts
  • CNTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LOAN Real Estate
  • CNTX Health Care
  • Exchange
  • LOAN Nasdaq
  • CNTX Nasdaq
  • Market Cap
  • LOAN 57.7M
  • CNTX 60.7M
  • IPO Year
  • LOAN 1999
  • CNTX 2021
  • Fundamental
  • Price
  • LOAN $5.39
  • CNTX $0.84
  • Analyst Decision
  • LOAN
  • CNTX Strong Buy
  • Analyst Count
  • LOAN 0
  • CNTX 5
  • Target Price
  • LOAN N/A
  • CNTX $6.50
  • AVG Volume (30 Days)
  • LOAN 34.1K
  • CNTX 257.9K
  • Earning Date
  • LOAN 04-29-2025
  • CNTX 05-07-2025
  • Dividend Yield
  • LOAN 8.63%
  • CNTX N/A
  • EPS Growth
  • LOAN 2.37
  • CNTX N/A
  • EPS
  • LOAN 0.49
  • CNTX N/A
  • Revenue
  • LOAN $7,351,609.00
  • CNTX N/A
  • Revenue This Year
  • LOAN N/A
  • CNTX N/A
  • Revenue Next Year
  • LOAN $2.18
  • CNTX N/A
  • P/E Ratio
  • LOAN $10.90
  • CNTX N/A
  • Revenue Growth
  • LOAN 1.12
  • CNTX N/A
  • 52 Week Low
  • LOAN $4.74
  • CNTX $0.55
  • 52 Week High
  • LOAN $6.05
  • CNTX $2.75
  • Technical
  • Relative Strength Index (RSI)
  • LOAN 48.35
  • CNTX 56.99
  • Support Level
  • LOAN $4.83
  • CNTX $0.80
  • Resistance Level
  • LOAN $5.38
  • CNTX $0.89
  • Average True Range (ATR)
  • LOAN 0.25
  • CNTX 0.11
  • MACD
  • LOAN -0.02
  • CNTX 0.03
  • Stochastic Oscillator
  • LOAN 49.62
  • CNTX 73.80

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: